Margus Viigimaa
Margus Viigimaa publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism, on topics such as Lipoproteins and Cardiovascular Health, Blood Pressure and Hypertension Studies and Cardiovascular Health and Disease Prevention.
- World rank
- #206,454 of 7,710,434 ranked researchers
- Rank in Estonia
- #202 of 4,874
- Works
- 235
- Citations
- 42k
- Citations per work
- 178.5
What does Margus Viigimaa research?
Margus Viigimaa's work is mostly in Medicine (46%), Engineering (4%), Biochemistry, Genetics and Molecular Biology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences10946.2%
- Medicine10946.2%
- Everything else10142.8%
- Physical Sciences114.5%
- Engineering114.5%
- Life Sciences83.3%
- Social Sciences83.2%
- 1Cardiology and Cardiovascular Medicine24% of their works
- 2Surgery14% of their works
- 3Endocrinology, Diabetes and Metabolism8% of their works
- 4Biomedical Engineering4% of their works
- 5Genetics3% of their works
- 6Economics and Econometrics3% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Blood Pressure and Hypertension Studies
- Cardiovascular Health and Disease Prevention
- Non-Invasive Vital Sign Monitoring
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hemodynamic Monitoring and Therapy
- Heart Rate Variability and Autonomic Control
- Genetic Associations and Epidemiology
Which keywords describe Margus Viigimaa's research?
The keywords of their largest research topics: Cardiovascular Disease, Cardiovascular Events, Hypertension, Cholesterol-lowering, Statins, Antihypertensive Drugs, Blood Pressure and Heart Rate Variability.
- Genome-Wide Association
- Physiological Time Series
- Hemodynamic Monitoring
- Metabolic Syndrome
- Remote Monitoring
- Endothelial Dysfunction
- Heart Rate Variability
- Antihypertensive Drugs
- Cholesterol-lowering
- Cardiovascular Events
- Cardiovascular Disease
- Hypertension
- Statins
- Blood Pressure
- Arterial Stiffness
- Photoplethysmography
- Diabetes
- Fluid Responsiveness
- Autonomic Nervous System
- Genetic Variation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Cardiovascular Disease783 topics
- Cardiovascular Events712 topics
- Hypertension712 topics
- Cholesterol-lowering511 topic
- Statins511 topic
- Antihypertensive Drugs411 topic
- Blood Pressure411 topic
- Heart Rate Variability392 topics
- Arterial Stiffness301 topic
- Endothelial Dysfunction301 topic
- Photoplethysmography271 topic
- Remote Monitoring271 topic
- Diabetes251 topic
- Metabolic Syndrome251 topic
- Fluid Responsiveness161 topic
- Hemodynamic Monitoring161 topic
- Autonomic Nervous System121 topic
- Physiological Time Series121 topic
- Genetic Variation101 topic
- Genome-Wide Association101 topic
Where does Margus Viigimaa work?
Margus Viigimaa's main affiliation in the publication record is Tallinn University of Technology, Estonia.
How many publications and citations does Margus Viigimaa have?
OpenAlex counts 235 works and 41,936 citations for Margus Viigimaa, an h-index of 51, ranking #206,454 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Margus Viigimaa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.